These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Ekstrand AJ; James CD; Cavenee WK; Seliger B; Pettersson RF; Collins VP Cancer Res; 1991 Apr; 51(8):2164-72. PubMed ID: 2009534 [TBL] [Abstract][Full Text] [Related]
3. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA. Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018 [TBL] [Abstract][Full Text] [Related]
4. Localization of aberrant messenger RNA of epidermal growth factor receptor (EGFR) in malignant glioma. Tsugu A; Kijima H; Yamazaki H; Ohnishi Y; Takamiya Y; Abe Y; Ueyama Y; Sato O; Tamaoki N; Nakamura M Anticancer Res; 1997; 17(3C):2225-32. PubMed ID: 9216693 [TBL] [Abstract][Full Text] [Related]
5. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein. Wiechen K; Zimmer C; Dietel M Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256 [TBL] [Abstract][Full Text] [Related]
7. Suppression of EJ cells tumorigenicity. Tone T; Kashani-Sabet M; Funato T; Shitara T; Yoshida E; Kashfian BI; Horng M; Fodstadt O; Scanlon KJ In Vivo; 1993; 7(6A):471-6. PubMed ID: 8193263 [TBL] [Abstract][Full Text] [Related]
8. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA. Cai DW; Mukhopadhyay T; Roth JA Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963 [TBL] [Abstract][Full Text] [Related]
9. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides. Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863 [TBL] [Abstract][Full Text] [Related]
11. Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme. Luo X; Gong X; Tang CK Int J Cancer; 2003 May; 104(6):716-21. PubMed ID: 12640678 [TBL] [Abstract][Full Text] [Related]
12. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha. MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780 [TBL] [Abstract][Full Text] [Related]
13. Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblasts. Kilpatrick MW; Phylactou LA; Godfrey M; Wu CH; Wu GY; Tsipouras P Hum Mol Genet; 1996 Dec; 5(12):1939-44. PubMed ID: 8968747 [TBL] [Abstract][Full Text] [Related]
14. Function of aberrant EGFR in malignant gliomas. Sugawa N; Yamamoto K; Ueda S; Morita N; Kita M; Nishino H; Fushiki S; Okabe T Brain Tumor Pathol; 1998; 15(1):53-7. PubMed ID: 9879464 [TBL] [Abstract][Full Text] [Related]
15. Catalytic cleavage of the androgen receptor messenger RNA and functional inhibition of androgen receptor activity by a hammerhead ribozyme. Chen S; Song CS; Lavrovsky Y; Bi B; Vellanoweth R; Chatterjee B; Roy AK Mol Endocrinol; 1998 Oct; 12(10):1558-66. PubMed ID: 9773979 [TBL] [Abstract][Full Text] [Related]
16. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity. Liang H; O'Reilly S; Liu Y; Abounader R; Laterra J; Maher VM; McCormick JJ Int J Oncol; 2004 May; 24(5):1057-67. PubMed ID: 15067326 [TBL] [Abstract][Full Text] [Related]
17. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme. Dorai T; Kobayashi H; Holland JF; Ohnuma T Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323 [TBL] [Abstract][Full Text] [Related]
18. Reversion of the malignant phenotype of gastric cancer cell SGC7901 by c-erbB-2-specific hammerhead ribozyme. Bi F; Fan D; Hui H; Wang C; Zhang X Cancer Gene Ther; 2001 Nov; 8(11):835-42. PubMed ID: 11773973 [TBL] [Abstract][Full Text] [Related]
19. Triple ribozyme-mediated down-regulation of the retinoblastoma gene. Benedict CM; Pan W; Loy SE; Clawson GA Carcinogenesis; 1998 Jul; 19(7):1223-30. PubMed ID: 9683181 [TBL] [Abstract][Full Text] [Related]
20. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Nishikawa R; Ji XD; Harmon RC; Lazar CS; Gill GN; Cavenee WK; Huang HJ Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7727-31. PubMed ID: 8052651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]